Skip to main content

Lonnie Miller, RCVT

08/01/2008
In recent years, many changes in antithrombotic regimens and therapies in the settings of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI) have been realized. These therapies include the use of glycoprotein IIb/IIIa...
In recent years, many changes in antithrombotic regimens and therapies in the settings of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI) have been realized. These therapies include the use of glycoprotein IIb/IIIa...
In recent years, many changes in...
08/01/2008
Journal of Invasive Cardiology